Table 1.

Residual Enzyme Activity and Clinical Manifestations of PK-Deficient Patients

Subject Genotype PK Vmax (IU/g Hb)Clinical Data
1  476T/1529A (G159V/R510Q)  5.15 Hemolytic anemia  
2  884T/+ (A295V)  10.32 Heterozygote  
3  943A/1456T (E315K/R486W)  2.71 Hemolytic anemia, neonatal jaundice  
4  1022A/993A (G341D/D331Q)  8.9  Hydrops Fatalis  
5  1022A/? (G341D) Older Younger    2.3 3.5  Severe hemolylic anemia, neonatal jaundice (older sister) 
6-151 1511T/1511T (R504L)  9.96  Severe hemolytic anemia  
7  1528T/+ (R510Ter)  6.05  The mother of a child with severe hemolytic anemia  
Normal values  11.1-18.9   
Subject Genotype PK Vmax (IU/g Hb)Clinical Data
1  476T/1529A (G159V/R510Q)  5.15 Hemolytic anemia  
2  884T/+ (A295V)  10.32 Heterozygote  
3  943A/1456T (E315K/R486W)  2.71 Hemolytic anemia, neonatal jaundice  
4  1022A/993A (G341D/D331Q)  8.9  Hydrops Fatalis  
5  1022A/? (G341D) Older Younger    2.3 3.5  Severe hemolylic anemia, neonatal jaundice (older sister) 
6-151 1511T/1511T (R504L)  9.96  Severe hemolytic anemia  
7  1528T/+ (R510Ter)  6.05  The mother of a child with severe hemolytic anemia  
Normal values  11.1-18.9   

Abbreviation: IU, International units.

F0-151

Transfused monthly.

Close Modal

or Create an Account

Close Modal
Close Modal